A SECRET WEAPON FOR WHO MAKES COPYRIGHT

Novo Nordisk's pricing procedures from the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who has accused the company of selling price gouging, pointing out the stark distinction amongst U.S. costs and those in Europe and copyright.In Oct 2024, Novo Nordisk published a study on scientific journal Nature a few novel glucose-sen